Feb 26 |
Missed Out on CRISPR Therapeutics? My Best Gene-Editing Stock to Buy and Hold
|
Feb 24 |
Steven Cohen's Point72 Adds Caribou Biosciences Inc to Its Portfolio
|
Feb 12 |
2 Risky Gene-Editing Stocks to Buy in the New Bull Market if You Dare
|
Feb 7 |
Caribou Biosciences (NASDAQ:CRBU) Is In A Good Position To Deliver On Growth Plans
|
Feb 1 |
Caribou Biosciences: Under The Radar With Catalysts Approaching
|
Jan 25 |
Biotech And Pharma Diversification Pays Off
|
Jan 15 |
3 Biotech Stocks You Can Buy and Hold for the Next Decade
|
Jan 7 |
Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024
|
Dec 13 |
5 Things to Know Before The Stock Market Opens
|
Dec 13 |
3 Gene-Editing Stocks With the Potential to Mint Millionaires
|